Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Queensland Health
McKinsey
US Department of Justice
Express Scripts
Covington
Accenture
Mallinckrodt
Fish and Richardson
Cantor Fitzgerald

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205641

« Back to Dashboard

NDA 205641 describes ASMANEX HFA, which is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. Additional details are available on the ASMANEX HFA profile page.

The generic ingredient in ASMANEX HFA is mometasone furoate. There are twenty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 205641
Tradename:ASMANEX HFA
Applicant:Merck Sharp Dohme
Ingredient:mometasone furoate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 205641
Medical Subject Heading (MeSH) Categories for 205641
Suppliers and Packaging for NDA: 205641
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641 NDA Merck Sharp & Dohme Corp. 0085-4333 N 0085-4333-02
ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641 NDA Merck Sharp & Dohme Corp. 0085-4333 N 0085-4333-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.10MG/INH
Approval Date:Apr 25, 2014TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.20MG/INH
Approval Date:Apr 25, 2014TE:RLD:Yes

Expired US Patents for NDA 205641

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-001 Apr 25, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-001 Apr 25, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-002 Apr 25, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-002 Apr 25, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-002 Apr 25, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-002 Apr 25, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-001 Apr 25, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme ASMANEX HFA mometasone furoate AEROSOL, METERED;INHALATION 205641-001 Apr 25, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Dow
Covington
Merck
Federal Trade Commission
Cerilliant
Citi
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot